Epicardial Infarct Repair Using CorMatrix®-ECM: Clinical Feasibility Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2017

Conditions
Acute Coronary SyndromeHeart Failure
Interventions
DEVICE

Epicardial Infarct Repair with CorMatrix-ECM

CorMatrix-ECM-biomaterial will be surgically applied to the epicardial surface of the infarct myocardium at the time of coronary artery bypass surgery

PROCEDURE

Coronary Artery Bypass Grafting Surgery

All participants will undergo standard coronary artery bypass grafting surgery to treat coronary artery disease

Trial Locations (1)

T2N 2T9

University of Calgary, Calgary

Sponsors
All Listed Sponsors
collaborator

CorMatrix Cardiovascular, Inc.

INDUSTRY

lead

University of Calgary

OTHER